Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Jurnal Respirologi Indonesia Respiratory Science
Oinike, Irene
Unknown Affiliation
Health Professions Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Respiratory Science

 1 
Hematologic and Non-Hematologic Side Effects in Lung Cancer Patients Post Chemotherapy at Arifin Achmad General Hospital Oinike, Irene; Munir, Sri Melati
Respiratory Science Vol. 6 No. 1 (2025): Respiratory Science
Publisher : Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/respirsci.v6i1.186

Abstract

Background: Lung cancer is the second-highest cause of malignancy in the world, with a prevalence of 11.4% of all types of cancer. The majority of lung cancer patients are diagnosed at an advanced stage; therefore, chemotherapy acts as palliative therapy without curative therapy options. Chemotherapy drugs have various side effects, both hematologic and non-hematologic. Thus, monitoring side effects should be notable to improve the quality of life for patients with lung cancer undergoing chemotherapy. Method: This research was a descriptive study with a total sampling data collection technique. Samples were collected for 6 months according to the inclusion criteria, and the results were presented in the form of a distribution table. Results: During August 2023 to January 2024, 29 lung cancer patients met the inclusion criteria at Arifin Achmad General Hospital. Of these 29 patients, 25 (86.21%) were men and 4 (13.79%) were women. The hematologic side effects were observed in 16 (55.17%) patients, while non-hematologic side effects were found in 18 (62.07%) patients. The most common hematologic side effect is anemia, and the most common non-hematologic side effect is gastrointestinal disorders. Conclusion: The chemotherapy regimen used for lung cancer patients caused both hematologic and non-hematologic side effects. The non-hematologic side effects were more common than the hematologic.
Co-Authors Sri Melati Munir Wijaya, Dewi